DoorDash Consensus Estimates Point To $33.7 Million In Positive EBITDA

DoorDash (NYSE: DASH) will be reporting their first-quarter financial results this evening after market close. Analysts have a consensus $172.27 12-month price target on the company, via a total of 20 analysts, with two analysts having strong buy ratings, four analysts having buy ratings, and 14 have hold ratings. The street high comes from JMP Securities with a $195 price target, and the lowest target sits at $153 from Evercore ISI.

19 analysts have revenue estimates for the first quarter. The mean revenue estimate between all 19 analysts is $993.32 million; this number has been revised upwards slightly from $975.61 million at the start of the year. The highest revenue estimate is $1.06 billion, while the lowest is $926 million.

The analyst consensus for net income for the first quarter is ($93.97) million, this is down from the start of the year at $31.06 million. The highest net income estimate is $0.5 million, while the lowest is ($269) million.

Onto EBITDA estimates, there are currently 17 analysts who have first-quarter EBITDA estimates. The mean is currently $33.65 million, with this number having been revised down from $98.91 million at the start of the year. The street high estimate currently sits at $48.90 million in EBITDA and the lowest is $22.87 million.

Analysts estimate that quarterly earnings per share will come in at ($0.26), with this number being down from $0.08 at the start of the year. The street high is $0.00 and the lowest estimate is ($0.70) per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

This Gold Story Starts With Cash Flow | Gordon Robb – ESGold

Silverco Cusi Mine PEA: Bigger Isn’t Always Better

Fixing Heart Disease Tied to Sudden Death in Young People | David Elsley – Cardiol Therapeutics

Recommended

Silver47 Eyes Discovery in Nevada After Tripling Kennedy Project Footprint

Total Metals Secures High Grade Critical Minerals Property In Northwestern Ontario

Related News

Tesla: Canaccord Bumps Price Target Up To $940 After AGM

Thursday night, on October 7th, Tesla (NASDAQ: TSLA) held their annual general meeting, where Elon...

Saturday, October 9, 2021, 01:06:00 PM

Lundin Mining: BMO Resumes Coverage, Gifts Lift To Price Target

Last week Lundin Mining Corporation (TSX: LUN) announced that it closed its acquisition of Josemaria...

Monday, May 2, 2022, 04:35:00 PM

K92 Mining Sees BMO Reiterate $11 Price Target Following Q3 Production Results

On October 6th, K92 Mining Inc. (TSX: KNT) reported it’s third-quarter production results. The company...

Tuesday, October 11, 2022, 11:19:00 AM

NG Energy: Beacon Reiterates Buy Rating, Suggests Firm Could Move Beyond $2.80 Price Target

On January 4th, NG Energy (TSXV: GASX) announced that it has completed all civil works and...

Sunday, January 9, 2022, 11:17:00 AM

WeedMD: Canaccord Initiates Coverage With $0.60 Price Target

Yesterday morning, Canaccord Genuity initiated coverage on WeedMD Inc (TSXV: WMD) with a C$0.60 12-month...

Thursday, March 25, 2021, 11:47:00 AM